FindTrial
Sign In

A Study to Assess the Effects on Serum Calcium When Teriparatide is used with Active Vitamin D in Osteoporosis Patients

A Study to Assess the Effects on Serum Calcium When Teriparatide is used with Active Vitamin D in Osteoporosis Patients

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080221547
Enrollment
Unknown
Registered
2011-08-26
Start date
2011-08-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

investigational material(s) Generic name etc : Teriparatide (LY333334) INN of investigational material : Therapeutic category code : 243 Thyroid and para-thyroid hormone preparations Dosage and Admin

Sponsors

Eli Lilly Japan K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ambulatory Japanese males or postmenopausal females with osteoporosis, as determined by the Japanese Society for Bone and Mineral Research (JSBMR) diagnostic criteria

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026